Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.biocon.com | |
Market Cap | 38,773.38 Cr. | |
Enterprise Value(EV) | 41,893.86 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.40 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 59.74 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 28.47 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 70.24 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 4.59 | Calculated using Price: 322.65 |
Dividend Yield | 0.15 | Period Ending 2021-03 |
No. of Shares Subscribed | 120.06 Cr. | 1,200,600,000 Shares |
FaceValue | 5 | |
Company Profile | ||
Biocon Limited is engaged in the manufacture of biotechnology products and research services. The Company is a public limited company incorporated and domiciled in India. The Company’s shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India. Business area of the company The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development. Products
1985:
2000:
2001:
2003:
2004:
2006:
2007:
2008:
2009:
2011:
2012:
2013:
2014:
2015:
2016:
2017:
2018:
2019:
2020:
Milestones
|
1 Day |
|
+3.47% |
1 Week |
|
+2.31% |
1 Month |
|
-5.35% |
3 Month |
|
-15.02% |
6 Month |
|
-9.06% |
1 Year |
|
-13.00% |
2 Year |
|
-3.79% |
5 Year |
|
+104.35% |
10 Year |
|
+826.94% |
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 21.50 | 15.68 | 17.22 | 16.31 | 15.37 | 8.74 | 18.00 | 14.26 | 13.16 | |
Return on Capital Employed (%) | 22.47 | 15.75 | 15.30 | 13.93 | 12.59 | 8.92 | 16.11 | 14.35 | 11.30 | |
Return on Assets (%) | 12.28 | 8.47 | 8.72 | 7.96 | 7.64 | 4.55 | 9.25 | 6.94 | 5.73 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
Shh. Funds | 2,695 | 3,027 | 3,271 | 4,034 | 4,838 | 5,181 | 6,098 | 6,706 | 7,627 | 8,433 | |
Non Curr. Liab. | 666 | 1,262 | 1,378 | 2,421 | 2,305 | 2,007 | 2,122 | 2,685 | 5,497 | 6,803 | |
Curr. Liab. | 990 | 1,380 | 1,555 | 1,666 | 1,678 | 2,141 | 3,039 | 4,008 | 4,210 | 3,828 | |
Minority Int. | 65 | 82 | 172 | 266 | 376 | 468 | 609 | 677 | 881 | 1,038 | |
Equity & Liab. | 4,416 | 5,751 | 6,375 | 8,387 | 9,197 | 9,796 | 11,868 | 14,076 | 18,215 | 20,101 | |
Non Curr. Assets | 2,176 | 3,112 | 3,813 | 4,416 | 5,149 | 5,648 | 6,979 | 8,751 | 10,614 | 11,718 | |
Curr. Assets | 2,240 | 2,639 | 2,563 | 3,971 | 4,048 | 4,149 | 4,889 | 5,325 | 7,600 | 8,382 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4,416 | 5,751 | 6,375 | 8,387 | 9,197 | 9,796 | 11,868 | 14,076 | 18,215 | 20,101 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. TTM |
Net Sales | 2,485 | 2,877 | 3,090 | 3,347 | 3,891 | 4,123 | 5,514 | 6,301 | 7,106 | 8,184 | |
Other Income | 57 | 56 | 53 | 84 | 157 | 206 | 414 | 508 | 605 | 268 | |
Total Income | 2,542 | 2,933 | 3,143 | 3,431 | 4,048 | 4,330 | 5,929 | 6,808 | 7,711 | 8,452 | |
Total Expenditure | -1,946 | -2,190 | -2,394 | -2,584 | -2,912 | -3,294 | -4,391 | -5,044 | -5,804 | -6,269 | |
PBIDT | 596 | 743 | 749 | 847 | 1,137 | 1,035 | 1,538 | 1,765 | 1,907 | 2,183 | |
Interest | -8 | -2 | -9 | -29 | -26 | -62 | -71 | -65 | -58 | -68 | |
Depreciation | -179 | -204 | -221 | -249 | -277 | -385 | -448 | -552 | -715 | -814 | |
Taxation | -98 | -107 | -96 | -142 | -162 | -157 | -212 | -315 | -222 | -212 | |
Exceptional Items | 202 | 105 | 161 | 195 | 68 | 13 | -111 | ||||
PAT | 513 | 431 | 528 | 587 | 672 | 432 | 1,002 | 900 | 925 | 979 | |
Minority Interest | -4 | -17 | -31 | -59 | -76 | -81 | -97 | -123 | -106 | -123 | |
Share Associate | 22 | 16 | 21 | 1 | -29 | -79 | -207 | ||||
Other Related Items | |||||||||||
Consolidated Net Profit | 509 | 414 | 497 | 550 | 612 | 372 | 905 | 748 | 741 | 648 | |
Adjusted EPS | 4 | 3 | 4 | 5 | 5 | 3 | 8 | 6 | 6 | 5 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 564 | 471 | 561 | 211 | 371 | 640 | 662 | 1,155 | 1,283 | 1,160 | |
Cash Fr. Inv. | -360 | -376 | -938 | -509 | -1,142 | -499 | -684 | -714 | -1,559 | -3,625 | |
Cash Fr. Finan. | -186 | -9 | 426 | 186 | 1,068 | -178 | -240 | -242 | 388 | 2,564 | |
Net Change | 18 | 87 | 49 | -112 | 297 | -36 | -262 | 199 | 112 | 99 | |
Cash & Cash Eqvt | 369 | 474 | 557 | 463 | 758 | 710 | 449 | 659 | 825 | 897 |
Thu, 19 May 2022
Press Release
|
|
Fri, 13 May 2022
Related Party Transaction
|
|
Thu, 12 May 2022
Related Party Transaction
|
Thu, 19 May 2022 |
|
|
|
|
|